Akthelia Pharmaceuticals
Akthelia Pharmaceuticals
Akthelia Pharmaceuticals

Pharmaceutical drug development

Akthelia is looking for an R&D Manager. Our lead AKT-011 programme, a small molecule, orally available NCE, is targeting the very large opportunity to improve outcomes in cancer chemotherapy and we have IP around a broad class of compound with potential application to many areas of medicine with high unmet need. Our approach is to upregulate the innate immunology of epithelial surfaces. The AKT-011 is at late preclinical stage, we plan to start human studies in 2026.

Helstu verkefni og ábyrgð
  • Develop and manage project timelines, budgets, and resources, and report project status to internal parties (executive team, board of directors) and external parties incl third party providers.
  • Establish and maintain relationships with CROs and other external partners to ensure timely and high-quality delivery of preclinical and clinical development activities.
  • Identify and manage project risks and develop mitigation strategies to ensure that project objectives are achieved.
  • Monitor compliance with regulatory requirements and guidelines for IND preparation.
  • Coordinate and lead project team meetings to ensure alignment and effective communication among team members.
  • Oversee the preparation and submission of the IND package to the regulatory authorities.
  • Identify grant funding opportunities and write up compelling proposals and statement of work, submit and manage grant proposals, and furnish prospective funders with supporting documents.
Menntunar- og hæfniskröfur
  • Graduate or higher studies in a relevant scientific or medical field.
  • Good project management skills, with the ability to develop and manage a project timeline within budget.
  • Preferable:
    • 1-3 years of experience in clinical development and medical affairs in the biotech or pharmaceutical industry.
    • Good understanding of preclinical and clinical development and medical affairs, including study design, execution, and reporting, FDA, EMA and ICH guidelines and regulations.
    • Ability to identify and manage clinical development and medical affairs risks.
    • Knowledge of CMC and drug development.
Auglýsing birt7. mars 2025
UmsóknarfresturEnginn
Tungumálahæfni
EnskaEnska
Nauðsyn
Mjög góð
Staðsetning
Grandagarður 16, 101 Reykjavík
Starfstegund
Hæfni
PathCreated with Sketch.ÁætlanagerðPathCreated with Sketch.FrumkvæðiPathCreated with Sketch.FræðigreinarPathCreated with Sketch.RannsóknirPathCreated with Sketch.Sjálfstæð vinnubrögðPathCreated with Sketch.SkipulagPathCreated with Sketch.SkýrslurPathCreated with Sketch.Uppbygging vinnsluskrárPathCreated with Sketch.VerkefnastjórnunPathCreated with Sketch.Vinnsla rannsóknargagna
Starfsgreinar
Starfsmerkingar